Friday, October 28, 2011

Taking an MBA Course in Pharmacoeconomics

This weekend, I'm taking an MBA course in pharmacoeconomics with other students who work in the pharmaceutical, biotechnology, and health care industries. It's great to have an opportunity to take a course that is so relevant to what I do on a regular basis. In our company (MCM), we develop continuing medical education (CME) activities for managed care professionals and we're dealing with pharmacoeconomic issues all the time. In health care, we grapple with challenging issues like cost-effectiveness, cost-consequence, cost-minimization, cost-utility, or cost-benefit of medical therapies. I look forward to the discussions we'll be having in class about these things.

I am approximately 1/3 of the way through my MBA program at this point. This will be my 7th MBA course this year.

Here's a brief course description:
This course reviews the principal elements and concepts in economics, history and development of health economics, and the applied uses of the discipline of economics made possible since the quantification of studies has been developed and perfected. These introductory sections are presented by lecture and discussion group. In addition, the need for uses of, and value of health economics studies is reviewed and pharmaceutical-related examples are presented.

About my Business School Blog:

I am currently a business school student in the Pharmaceutical and Healthcare Executive MBA program at Saint Joseph's University Erivan K. Haub School of Business in Philadelphia, PA. The Nationally-ranked and AACSB-accredited Haub School of Business, centrally located in the mid-Atlantic pharmaceutical and healthcare corridor, is able to bring together industry experts and a world-class faculty for a unique industry-focused, immersive executive program.

You can read about my business school experience by reading all the blog posts tagged "Business School Blog."

No comments:

Post a Comment

Blog Widget by LinkWithin